Back to search
FDAFDA · Food and drugs·Recall number D-0436-2024

FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1

Published April 10, 2024 · Recall initiated: February 29, 2024

Summary

FDA records drug Class II recall D-0436-2024, published April 10, 2024 and initiated February 29, 2024. Recalling firm: SSM Health Care St. Louis DBA SSM St. Clare Health Center; Status: Ongoing; Reported quantity: 140 vials; Lot: Lot: 20231031-0C91D9, Exo 29-Feb-2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Firm did not perform process validation.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SSM Health Care St. Louis DBA SSM St. Clare Health Center
Distributor
MO
Lot
Lot: 20231031-0C91D9, Exo 29-Feb-2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1 recalled?

Yes. FDA published recall D-0436-2024 on April 10, 2024. Reported hazard: Lack of Assurance of Sterility: Firm did not perform process validation.

What should I do if I have this product?

Voluntary: Firm initiated · Letter